Krsnaa Diagnostics Ltd
NSE: KRSNAA · Healthcare Service Provider · sector
₹498.45NSE close 2026-10-26
Key numbers
Market cap₹1,617 cr
Price₹498.45
52w high / low₹838 / ₹498
P/E16.6xSector median 22.9x
P/B1.6xSector median 2.0x
Book value₹302.2
Dividend yield0.55%Sector median 0.55%
ROE10.5%Sector median 5.4%
ROCE11.1%Sector median 6.8%
OPM26.8%Sector median 15.9%
Debt / equity0.55xSector median 0.07x
EV/EBITDA8.2xSector median 17.2x
Interest cover3.9x
Current ratio2.68x
Sales growth 3y+16.6%Sector median +13.5%
Profit growth 3y+17.8%Sector median +26.9%
PEG1.01x
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 31 companies in Healthcare Service Provider (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹361 cr vs borrowings ₹534 cr (FY26): borrowings are higher by ₹174 cr.
- Borrowings rose in each of the last 3 years (₹32 cr → ₹534 cr).
- Operating profit covered interest 3.9x in the last 12 months.
- Operating cash flow was below net profit in 1 of the last 5 years (FY24).
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 48% of net profit in the last 12 months.
- Debtor days went from 104 (FY24) to 140 (FY26).
- Dividend paid in 4 of the last 5 financial years.
- Price ₹498.45 on 2026-10-26: -40.5% from the 52-week high, 0.0% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹1,001.55 · low ₹498.45
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 186 | 175 | 186 | 193 | 206 | 181 | 193 | 236 |
| EBITDA | 49 | 45 | 53 | 51 | 59 | 46 | 55 | 58 |
| OPM % | 26.5% | 25.8% | 28.5% | 26.6% | 28.7% | 25.6% | 28.5% | 24.6% |
| Other income | 5 | 9 | 4 | 4 | 4 | 4 | 32 | 7 |
| Net profit | 20 | 19 | 21 | 21 | 24 | 15 | 42 | 17 |
| EPS (₹) | 6.07 | 6.01 | 6.40 | 6.35 | 7.38 | 4.72 | 12.86 | 5.10 |
| Revenue YoY | +10.5% | +3.8% | +3.5% | +22.0% | ||||
| Profit YoY | +22.2% | -21.4% | +101.7% | -19.3% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 455 | 487 | 620 | 717 | 773 | 815 |
| EBITDA | 131 | 122 | 144 | 190 | 212 | 218 |
| Net profit | 68 | 62 | 57 | 78 | 101 | 97 |
| EPS (₹) | 22.89 | 19.78 | 17.90 | 24.04 | 31.30 | 30.06 |
| Revenue growth | +7.0% | +27.2% | +15.7% | +7.8% | +10.2% | |
| Profit growth | -9.2% | -8.5% | +36.5% | +30.7% | +21.5% | |
| Dividend / share (₹) | – | 2.50 | 2.75 | 2.50 | 2.75 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +16.6% | – | +10.2% |
| Net profit | +17.8% | – | +21.5% |
| EPS | +16.5% | – | – |
| Share price | – | -21.3% (2y) | -36.3% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 739 | 810 | 883 | 980 |
| Borrowings | – | 32 | 160 | 204 | 534 |
| Cash & equivalents | – | 109 | 54 | 68 | 361 |
| Total assets | – | 910 | 1,172 | 1,282 | 1,824 |
| Fixed assets | – | 468 | 645 | 667 | 652 |
| Capital work in progress | – | 25 | 10 | 3 | 208 |
| Investments | – | 0 | 0 | 32 | 57 |
| Receivables | – | 73 | 176 | 278 | 296 |
| Inventory | – | 25 | 36 | 29 | 27 |
| Payables | – | 62 | 82 | 97 | 63 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 128 | 76 | 24 | 87 | 143 |
| Cash from investing | -241 | -109 | -129 | -100 | -396 |
| Cash from financing | 176 | -33 | 84 | 14 | 279 |
| Capex | 132 | 141 | 194 | 127 | 219 |
| Free cash flow | -4 | -65 | -170 | -39 | -76 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 8.4% | 7.0% | 8.8% | 10.3% |
| ROCE % | – | 11.4% | 8.9% | 11.7% | 10.9% |
| Debtor days | – | 55 | 104 | 141 | 140 |
| Inventory days | – | 123 | 93 | 64 | 54 |
| Payable days | – | 306 | 213 | 209 | 129 |
| Cash conversion cycle (days) | – | -128 | -16 | -4 | 65 |
| Working capital days | – | 95 | 82 | 56 | 219 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 27.11% |
| FIIs | 3.84% |
| DIIs | 14.50% |
| of which Mutual funds | 10.17% |
| of which Insurance | 2.67% |
| Government | 0.00% |
| Public (non-institutions) | 54.54% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 27.24% | 27.24% | 27.11% | 27.11% | 27.11% | 27.11% | 27.11% | 27.11% |
| Promoter group | % |
|---|---|
| Rajendra Khivraj Mutha | 24.75% |
| Krsna Diagnostics (Mumbai) Private Limited | 2.36% |
| Public holders above 1% | % |
|---|---|
| PHI Capital Trust - PHI Capital Growth Fund - I | 15.37% |
| Tata Mutual Fund - Tata Small CAP Fund | 8.04% |
| Amicorp Capital (Mauritius) Limited | 2.18% |
| HDFC Life Insurance Company Limited | 2.04% |
| Bandhan Small CAP Fund | 1.98% |
| Medimaze Solutions Private Limited | 1.03% |
50,671 shareholders. Pledged: – of promoter shares.
Peers in Healthcare Service Provider
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| LALPATHLAB | ₹31,100 cr | 57.2x | 12.4x | 23.1% | 29.6% | 27.9% | +11.1% | 0.71% |
| VIJAYA | ₹14,362 cr | 76.6x | 15.0x | 21.4% | 30.1% | 42.2% | +21.0% | 0.14% |
| METROPOLIS | ₹10,989 cr | 54.5x | 7.3x | 14.2% | 19.7% | 24.2% | +12.8% | 0.19% |
| THYROCARE | ₹7,491 cr | 42.6x | 12.8x | 31.1% | 39.7% | 31.4% | +16.3% | 1.99% |
| NEPHROPLUS | ₹6,095 cr | 71.6x | 5.5x | 6.9% | 13.4% | 22.7% | – | – |
| SURAKSHA | ₹1,628 cr | 45.4x | 6.7x | 15.7% | 25.2% | 31.4% | – | – |
| KRSNAA | ₹1,617 cr | 16.6x | 1.6x | 10.5% | 11.1% | 26.8% | +16.6% | 0.55% |
| 3BBLACKBIO | ₹1,193 cr | 21.2x | 3.7x | 18.7% | 22.8% | 34.9% | +127.8% | 0.29% |
| HEALTHX | ₹857 cr | – | 3.2x | -0.5% | – | – | – | – |
| ONEGLOBAL | ₹773 cr | 10.5x | 5.5x | 69.4% | 69.9% | 19.2% | +201.8% | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-09-18 | Dividend | Dividend - Rs 2 Per Share |
| 2025-09-12 | Dividend | Dividend - Rs 2.75 Per Share |
| 2024-09-13 | Dividend | Dividend - Rs 2.50 Per Share |
| 2024-09-13 | Other | Annual General Meeting |
| 2023-09-15 | Other | Annual General Meeting |
| 2023-09-15 | Dividend | Dividend - Rs 2.75 Per Share |
| 2022-09-15 | Dividend | Dividend - Rs 2.50 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Diagnostic and Related Healthcare Services: The Company is primarily engaged in the business of providing Diagnostic Services primarily in relation to Pathology Investigation, Radiology Investigation and Tele reporting.
| Sector | Healthcare |
| Industry | Healthcare Service Provider |
| Sub-industry | Healthcare Service Provider |
| Symbol | KRSNAA |
| BSE code | 543328 |
| ISIN | INE08LI01020 |
| Face value | ₹5.0 |
| Incorporated | 2010-12-22 |
| Website | www.krsnaadiagnostics.com |
| Plants (India / abroad) | 0 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.